期刊文献+

甲状腺激素与阿尔茨海默病的关系 被引量:5

暂未订购
导出
摘要 目的探讨甲状腺激素(TH)在阿尔茨海默病(AD)患者中的变化,以及对AD患者预后的影响。方法选取2005年2月~2008年4月在我院住院的44名AD组患者和44名健康体检者(对照组),采用化学发光法分析血清四碘甲状腺原氨酸(T4)、三碘甲状腺原氨酸(T3)、游离甲状腺激素(FT3、FT4)和促甲状腺素(TSH)的浓度,并以治疗前后简易智能精神状态量表(MMSE)评分差值来评估AD患者的预后,用多元线性回归法分析年龄、性别、血清T4浓度和TSH浓度对AD预后的影响。结果AD组患者血清T4(t=-6.805,P=0.000)、T3(t=-9.347,P=0.000)、FT3(t=-21.895,P=0.000)、FT4(t=-5.534,P=0.000)和TSH(t=-2.518,P=0.014)的浓度显著低于对照组,并且AD组患者的预后与血清T4浓度呈负相关(β=-0.305,t=-2.164,P=0.037),与TSH浓度呈正相关(β=0.449,t=3.180,P=0.003),以TSH浓度的影响最大。结论TH在AD患者中呈低水平表达,并影响AD患者的预后。
作者 张敏
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第6期750-751,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献8

  • 1Leys D. Cerebrovascular disease, cognitive impairment, and dementia [J]. J Neurosurg Psychiatry,2005 ;76(2) :300.
  • 2解恒革.阿尔茨海默病的流行病学[J].中国全科医学,2001,4(12):933-934. 被引量:7
  • 3王春玉,钱采韻,方莹莹.Alzheimer病血清胆固醇、血脂、叶酸、VB_(12)及甲状腺激素变化的临床研究[J].中国老年学杂志,2006,26(7):873-875. 被引量:18
  • 4周智林,梁丽贞,严永兴.阿尔茨海默病和血管性痴呆患者甲状腺功能的研究[J].中华神经科杂志,2005,38(2):116-117. 被引量:16
  • 5Kapaki E, Paraskevas GP, Mantzou E, et al. Thyroid function in patients with Alzheimer disease: implications on response to anticholinesterase treatment [ J]. Alzheimer Dis Assoc Disord ,2006 ;20 (4) : 242 -7.
  • 6Sampaolo S, Campos-Barros A, Mazziotti G, et al. Increased cerebrospinal fluid levels of 3,3',5 '-triiodothyronine in patients with Alzheimer's disease[ J]. J Clin Endocfinol Metab,2005 ;90( 1 ) : 198-202.
  • 7van Osch A, Hogervorst E, Combrinck M, et al. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease[J]. Neurology,2004 ;62 ( 11 ) : 1967-71.
  • 8Wahlin A, Wahli TB, Small B J, et al. Influences of thyroid stimulating hormone on cognitive function in very old age [ J]. J Gerontol, 1998 ; 53 (4) :234-9.

二级参考文献23

  • 1Jick H,Zornberg GL,Jick SS,et al.Statins and the risk of dementia[J].Lancet,2000;356(9242):1627-31.
  • 2Kivipelto M,Helkala EL,Hanninen T,et al.Midlife vascular risk factors and late-life mild cognitive impairment:a population-based study[J].Neurology,2001;56(12):1683-9.
  • 3Whyte E,Mulsant BH,Butters MA,et al.Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia[J].Am J Geriatr Psychiatry,2002;10:321-7
  • 4Eastley R,Wilcock GK,Bucks RS.Vitamin B12 deficiency in dementia and cognitive impairment:the effects of treatment on neuropsychological function[J].Int J Geriatr Psychiatry,2000;15:226-33.
  • 5Leblhuber F,Walli J,Artner-Dworzak E,et al.Hyperhomocysteinemia in dementia[J].J Neural Transm,2000;107:1469-74.
  • 6Cutler RG,Kelly J,Storie K,et al.Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease[J].Proc Natl Acad Sci USA,2004;101(7):2070-5.
  • 7Refolo LM,Pappolla MA,LaFrancois J,et al.A cholesterol-lowering drug reduces-β-amyloid pathology in a transgenic mouse model of Alzheimer's disease[J].Neurobiol Dis,2001;8(5):890-9.
  • 8Simons M,Keller P,De Strooper B,et al.Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons[J].Proc Natl Acad Sci USA,1998;95(11):6460-4.
  • 9Refolo LM,Malester B,LaFrancois J,et al.Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model[J].Neurobiol Dis,2000;7(4):321-31.
  • 10Kojro E,Gimpl G,Lammich S,et al.Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM10[J].Proc Natl Acad Sci USA,2001;98(10):5315-20.

共引文献36

同被引文献60

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部